...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Message: New Share Price Contest update to Oct 12th

In Canadian $, I am in for:

$10 for the cardio

$10 for CKD

$10 for Cognotion

so, the tally depends on what company reports between now and then!!!!

New Message
Please login to post a reply